Skip to main content

FDA Approvals

FDA Approvals
GLP-1 Agonists May Protect Patients with Diabetes from Heart Failure
Wayne Kuznar
Read More
FDA Approvals
Breo Ellipta: A Fixed-Dose Combination Oral Inhaler Receives FDA Approval for Long-Term Maintenance Treatment of COPD
Loretta Fala
Read More
FDA Approvals
Invokana (Canagliflozin): First-in-Class SGLT2 Inhibitor Approved for the Treatment of Type 2 Diabetes
Loretta Fala
Read More
FDA Approvals
SGLT-2 Inhibitors Show Durability in Glycemic Control, Weight-Loss Maintenance
Wayne Kuznar
Read More
FDA Approvals
Nesina, Kazano, and Oseni: Three Alogliptin-Based Agents Approved for the Treatment of Type 2 Diabetes
Loretta Fala
Read More
FDA Approvals
Tafinlar and Mekinist: Two Oral Targeted Kinase Inhibitors for the Treatment of Patients with Metastatic Melanoma and BRAF Mutations
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Pazopanib: First Positive Maintenance Trial in Ovarian Cancer
Phoebe Starr
Read More
FDA Approvals
Mekinist and Dabrafenib Approved for Advanced Melanoma with BRAF Mutations
Read More
FDA Approvals
Lenalidomide Receives New Indication for Mantle-Cell Lymphoma
Read More
Page 46 of 53
Results 451 - 460 of 522